Epizyme (NASDAQ: EPZM) filed a $69 million IPO prospectus Thursday. The company plans to list on the The ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE